Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 1Liver Neoplasms 1Klatskin Tumor 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1

Interventions

Fluorouracil 4Oxaliplatin 3Capecitabine 3toripalimab 2dehydroftorafur 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Leucovorin 2Biopsy 2tremelimumab 1trametinib 1tislelizumab 1temoporfin 1sacituzumab govitecan 1lenvatinib 1gemcitabine-oxaliplatin regimen 1durvalumab 1binimetinib 1Stents 1Sorafenib 1Radiosurgery 1Hydroxychloroquine 1Gemcitabine 1Erlotinib Hydrochloride 1Cisplatin 13-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Klatskin Tumor × 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide × Clear all
NCT03377179 2025-07-23

A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma

RedHill Biopharma Limited

Phase 2 Completed
65 enrolled
Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡